Replies to post #29687 on Entest Group Inc

[1~Eye~Jack!!]

~ ENTB = Immuno-Therapeutic Cancer Vaccine for Canines (Dog Cancer Vaccine)

The first area of focus involves the development of an immuno-therapeutic cancer vaccine for canines. One in every four dogs will develop some sort of cancer during its lifetime. The Company's goal in this area is to create a treatment that will jumpstart the dog's own immune system to fight cancer, and we have a device that is in development that we believe will be a "game-changer" for canine oncology. With the rollout of our "canines first" approach, Entest feels it can penetrate the veterinary market in the very near term (one to three years) and eventually take this immuno-therapeutic cancer vaccine into human trials once enough paid animal cases support our vaccine's efficacy. ;-)

[GM_FSJ]

Amazing... With a chart like that ENTB is a guaranteed money maker.